Dr Fatima Valdes Mora is Group Leader of Histone Variants in the Genomics and Epigenetics Division at the Garvan Institute of Medical Research (Sydney, Australia). She obtained her PhD in Molecular Biology, Biochemistry and Biomedicine from CSIC (Autonoma University of Madrid, Spain) in 2008. She then moved to Sydney to spend 5 years at the Cancer Epigenetic lab headed by Professor Susan Clark lab at the Garvan Institute for Medical Research (Australia). She obtained her current Group Leader position at the Garvan Institute in 2014. Fa is a mid-career researcher arising as authority in Cancer epigenetics research; she has played an integral role in discovering novel genome-wide roles of the acetylation of the histone variant H2A.Z and enable of international significance. She has a passion for development and implementation of novel technology that has allow her to develop a strong multidisciplinary profile on cancer epigenetics, molecular and cellular biology, next-generation sequencing methodologies, single cell transcriptomics and epigenomics and bioinformatics interpretation of genome-wide data.